Worthwhile to whom? Public expectations and the value of lecanemab

Kenichiro Sato
Psychiatry and Clinical Neurosciences · Wiley · 2026-11-09 · DOI: 10.1111/pcn.70171

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles